Context Therapeutics Inc. · NASDAQ:CNTX
Avidity Partners Management LP reported a 9.90% stake in Context Therapeutics Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Avidity Partners Management LP reported a 9.90% stake in Context Therapeutics Inc., 9,126,176 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 9,126,176
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avidity Partners Management LP | 9.90% | 9,126,176 |
| Avidity Partners Management (GP) LLC | 9.90% | 9,126,176 |
| Avidity Capital Partners Fund (GP) LP | 9.90% | 9,126,176 |
| Avidity Capital Partners (GP) LLC | 9.90% | 9,126,176 |
| Avidity Master Fund LP | 5.60% | 5,183,700 |
| Avidity Private Master Fund I LP | 8.40% | 7,776,296 |
| Michael Gregory | 9.90% | 9,126,176 |
Source
Related
- Context Therapeutics Inc.
- Avidity Partners Management LP
- Context Therapeutics Inc. shareholders
- Schedule 13G/A · Avidity Partners Management LP · May 12, 2026
- Schedule 13G/A · Avidity Partners Management LP · Nov 14, 2025
- Schedule 13G/A · Avidity Partners Management LP · Feb 14, 2025
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · Aug 12, 2026
- Schedule 13G/A · Octagon Capital Advisors LP · Jul 31, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · Great Point Partners LLC · May 15, 2026